Debanjan Ray's Net Worth
Debanjan Ray's net worth is estimated to be at least $1,976,341.12 as of 11/23/2024. CoreStreet's estimation of Debanjan Ray's net worth is based on their sale of stock and current holding of stock.
Debanjan Ray is CFO at CytomX Therapeutics Inc. They have executed at least 18 trades of stock as per SEC Form 4 filings. Their most recent trade was for 3,000 units of CTMX stock on 12/12/2018. Their biggest sale was on 03/02/2018 when they sold 33,000 units of CytomX Therapeutics Inc stock for $989,670.00. They typically trade 9 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $1,976,341.12
Most recent insider trade:
- Dec. 12, 2018
Debanjan Ray's Insider Trading History
| CytomX Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 12, 2018 | CFO | 3,000 | $15.00 | Sell | $45,000.00 |
Nov. 1, 2018 | CFO | 3,000 | $15.00 | Sell | $45,000.00 |
Oct. 1, 2018 | CFO | 3,000 | $18.46 | Sell | $55,380.00 |
Sept. 4, 2018 | CFO | 3,000 | $22.39 | Sell | $67,170.00 |
Aug. 1, 2018 | CFO | 3,000 | $26.05 | Sell | $78,150.00 |
July 2, 2018 | CFO | 3,000 | $22.56 | Sell | $67,680.00 |
June 1, 2018 | CFO | 3,000 | $25.93 | Sell | $77,790.00 |
May 1, 2018 | CFO | 3,000 | $26.52 | Sell | $79,560.00 |
April 2, 2018 | CFO | 3,000 | $28.12 | Sell | $84,360.00 |
March 2, 2018 | CFO | 33,000 | $29.99 | Sell | $989,670.00 |
Feb. 1, 2018 | CFO | 2,548 | $26.69 | Sell | $68,006.12 |
Jan. 2, 2018 | CFO | 2,500 | $21.11 | Sell | $52,775.00 |
Dec. 1, 2017 | CFO | 2,500 | $20.58 | Sell | $51,450.00 |
Nov. 1, 2017 | CFO | 2,500 | $20.00 | Sell | $50,000.00 |
Oct. 2, 2017 | CFO | 2,500 | $18.10 | Sell | $45,250.00 |
Sept. 1, 2017 | CFO | 2,500 | $17.17 | Sell | $42,925.00 |
Aug. 9, 2017 | CFO | 2,500 | $15.00 | Sell | $37,500.00 |
July 3, 2017 | CFO | 2,500 | $15.47 | Sell | $38,675.00 |